-
Je něco špatně v tomto záznamu ?
Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey
AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, M. Benghanem Gharbi, SN. Davison, M. Ghnaimat, P. Harden, H. Htay, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, VA. Luyckx, BL. Neuen, D....
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Europe PubMed Central
od 1981
ProQuest Central
od 2008-01-01
Nursing & Allied Health Database (ProQuest)
od 2008-01-01
Health & Medicine (ProQuest)
od 2008-01-01
PubMed
31672760
DOI
10.1136/bmj.l5873
Knihovny.cz E-zdroje
- MeSH
- celosvětové zdraví statistika a číselné údaje MeSH
- chronické selhání ledvin terapie MeSH
- dostupnost zdravotnických služeb statistika a číselné údaje MeSH
- lidé MeSH
- náhrada funkce ledvin statistika a číselné údaje MeSH
- nefrologie statistika a číselné údaje MeSH
- průřezové studie MeSH
- rozvojové země statistika a číselné údaje MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: To determine the global capacity (availability, accessibility, quality, and affordability) to deliver kidney replacement therapy (dialysis and transplantation) and conservative kidney management. DESIGN: International cross sectional survey. SETTING: International Society of Nephrology (ISN) survey of 182 countries from July to September 2018. PARTICIPANTS: Key stakeholders identified by ISN's national and regional leaders. MAIN OUTCOME MEASURES: Markers of national capacity to deliver core components of kidney replacement therapy and conservative kidney management. RESULTS: Responses were received from 160 (87.9%) of 182 countries, comprising 97.8% (7338.5 million of 7501.3 million) of the world's population. A wide variation was found in capacity and structures for kidney replacement therapy and conservative kidney management-namely, funding mechanisms, health workforce, service delivery, and available technologies. Information on the prevalence of treated end stage kidney disease was available in 91 (42%) of 218 countries worldwide. Estimates varied more than 800-fold from 4 to 3392 per million population. Rwanda was the only low income country to report data on the prevalence of treated disease; 5 (<10%) of 53 African countries reported these data. Of 159 countries, 102 (64%) provided public funding for kidney replacement therapy. Sixty eight (43%) of 159 countries charged no fees at the point of care delivery and 34 (21%) made some charge. Haemodialysis was reported as available in 156 (100%) of 156 countries, peritoneal dialysis in 119 (76%) of 156 countries, and kidney transplantation in 114 (74%) of 155 countries. Dialysis and kidney transplantation were available to more than 50% of patients in only 108 (70%) and 45 (29%) of 154 countries that offered these services, respectively. Conservative kidney management was available in 124 (81%) of 154 countries. Worldwide, the median number of nephrologists was 9.96 per million population, which varied with income level. CONCLUSIONS: These comprehensive data show the capacity of countries (including low income countries) to provide optimal care for patients with end stage kidney disease. They demonstrate substantial variability in the burden of such disease and capacity for kidney replacement therapy and conservative kidney management, which have implications for policy.
Beijing China Peking Tsinghua Center for Life Sciences Beijing China
Department of Community Health Sciences University of Calgary Calgary AB Canada
Department of Medicine University of Hong Kong Queen Mary Hospital Hong Kong
Department of Nephrology General University Hospital Charles University Prague Czech Republic
Department of Nephrology Kidney Foundation Hospital and Research Institute Dhaka Bangladesh
Department of Renal Medicine Singapore General Hospital Singapore
Dialysis Unit CASMU IAMPP Montevideo Uruguay
Division of Nephrology Bezmialem Vakif University Istanbul Turkey
Division of Nephrology Department of Medicine University of British Columbia Vancouver BC Canada
George Institute for Global Health Newtown NSW Australia
George Institute for Global Health University of New South Wales Sydney Sydney NSW Australia
Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia
Nephrology Division Department of Internal Medicine The Specialty Hospital Amman Jordan
Oxford Kidney Unit Oxford University Hospitals NHS Foundation Trust Oxford UK
Salford Royal NHS Foundation Trust Salford UK University of Manchester Manchester UK
University of Leicester Leicester UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044498
- 003
- CZ-PrNML
- 005
- 20200320111607.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1136/bmj.l5873 $2 doi
- 035 __
- $a (PubMed)31672760
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Bello, Aminu K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada aminu1@ualberta.ca.
- 245 10
- $a Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey / $c AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, GE. Ashuntantang, E. Bellorin-Font, M. Benghanem Gharbi, SN. Davison, M. Ghnaimat, P. Harden, H. Htay, V. Jha, K. Kalantar-Zadeh, PG. Kerr, S. Klarenbach, CP. Kovesdy, VA. Luyckx, BL. Neuen, D. O'Donoghue, S. Ossareh, J. Perl, HU. Rashid, E. Rondeau, E. See, S. Saad, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, R. Turan Kazancioglu, AY. Wang, N. Wiebe, CW. Yang, A. Zemchenkov, MH. Zhao, KJ. Jager, F. Caskey, V. Perkovic, KK. Jindal, IG. Okpechi, M. Tonelli, J. Feehally, DC. Harris, DW. Johnson,
- 520 9_
- $a OBJECTIVE: To determine the global capacity (availability, accessibility, quality, and affordability) to deliver kidney replacement therapy (dialysis and transplantation) and conservative kidney management. DESIGN: International cross sectional survey. SETTING: International Society of Nephrology (ISN) survey of 182 countries from July to September 2018. PARTICIPANTS: Key stakeholders identified by ISN's national and regional leaders. MAIN OUTCOME MEASURES: Markers of national capacity to deliver core components of kidney replacement therapy and conservative kidney management. RESULTS: Responses were received from 160 (87.9%) of 182 countries, comprising 97.8% (7338.5 million of 7501.3 million) of the world's population. A wide variation was found in capacity and structures for kidney replacement therapy and conservative kidney management-namely, funding mechanisms, health workforce, service delivery, and available technologies. Information on the prevalence of treated end stage kidney disease was available in 91 (42%) of 218 countries worldwide. Estimates varied more than 800-fold from 4 to 3392 per million population. Rwanda was the only low income country to report data on the prevalence of treated disease; 5 (<10%) of 53 African countries reported these data. Of 159 countries, 102 (64%) provided public funding for kidney replacement therapy. Sixty eight (43%) of 159 countries charged no fees at the point of care delivery and 34 (21%) made some charge. Haemodialysis was reported as available in 156 (100%) of 156 countries, peritoneal dialysis in 119 (76%) of 156 countries, and kidney transplantation in 114 (74%) of 155 countries. Dialysis and kidney transplantation were available to more than 50% of patients in only 108 (70%) and 45 (29%) of 154 countries that offered these services, respectively. Conservative kidney management was available in 124 (81%) of 154 countries. Worldwide, the median number of nephrologists was 9.96 per million population, which varied with income level. CONCLUSIONS: These comprehensive data show the capacity of countries (including low income countries) to provide optimal care for patients with end stage kidney disease. They demonstrate substantial variability in the burden of such disease and capacity for kidney replacement therapy and conservative kidney management, which have implications for policy.
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a rozvojové země $x statistika a číselné údaje $7 D003906
- 650 _2
- $a celosvětové zdraví $x statistika a číselné údaje $7 D014943
- 650 _2
- $a dostupnost zdravotnických služeb $x statistika a číselné údaje $7 D006297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a chronické selhání ledvin $x terapie $7 D007676
- 650 _2
- $a nefrologie $x statistika a číselné údaje $7 D009398
- 650 _2
- $a náhrada funkce ledvin $x statistika a číselné údaje $7 D017582
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Levin, Adeera $u Division of Nephrology, Department of Medicine, University of British Columbia, Vancouver, BC, Canada.
- 700 1_
- $a Lunney, Meaghan $u Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
- 700 1_
- $a Osman, Mohamed A $u University of Ottawa, Ottawa, ON, Canada.
- 700 1_
- $a Ye, Feng $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Ashuntantang, Gloria E $u Faculty of Medicine and Biomedical Sciences, Yaounde General Hospital, University of Yaounde I, Yaounde, Cameroon.
- 700 1_
- $a Bellorin-Font, Ezequiel $u Division of Nephology and Hypertension, Department of Medicine, Saint Louis University, Saint Louis, MO, USA.
- 700 1_
- $a Benghanem Gharbi, Mohammed $u Urinary Tract Diseases Department, Faculty of Medicine and Pharmacy of Casablanca, University Hassan II of Casablanca, Casablanca, Morocco.
- 700 1_
- $a Davison, Sara N $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Ghnaimat, Mohammad $u Nephrology Division, Department of Internal Medicine, The Specialty Hospital, Amman, Jordan.
- 700 1_
- $a Harden, Paul $u Oxford Kidney Unit, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
- 700 1_
- $a Htay, Htay $u Department of Renal Medicine, Singapore General Hospital, Singapore.
- 700 1_
- $a Jha, Vivekanand $u George Institute for Global Health, UNSW, New Delhi, India. Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK. Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India.
- 700 1_
- $a Kalantar-Zadeh, Kamyar $u Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, CA, USA. UCLA Fielding School of Public Health in Irvine and Los Angeles, CA, USA.
- 700 1_
- $a Kerr, Peter G $u Department of Nephrology, Monash Medical Centre, Monash Health, Clayton, VIC, Australia. Department of Medicine, Monash University, Clayton, VIC, Australia.
- 700 1_
- $a Klarenbach, Scott $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Kovesdy, Csaba P $u Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA. Memphis VA Medical Center, Memphis, TN, USA.
- 700 1_
- $a Luyckx, Valérie Ann, $d 1967- $7 xx0245981 $u Institute of Biomedical Ethics and the History of Medicine, University of Zurich, Zurich, Switzerland. Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Neuen, Brendon L $u George Institute for Global Health, Newtown, NSW, Australia.
- 700 1_
- $a O'Donoghue, Donal $u Salford Royal NHS Foundation Trust, Salford, UK. University of Manchester, Manchester, UK.
- 700 1_
- $a Ossareh, Shahrzad $u Division of Nephrology, Department of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.
- 700 1_
- $a Perl, Jeffrey $u Division of Nephrology, St Michael's Hospital and the Keenan Research Centre in the Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, ON, Canada. Division of Nephrology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
- 700 1_
- $a Rashid, Harun Ur $u Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh.
- 700 1_
- $a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Hopital Tenon, Assistance Publique-Hopitaux de Paris, Paris, France. Sorbonne Université, Paris, France.
- 700 1_
- $a See, Emily $u Department of Intensive Care, Austin Health, Melbourne, VIC, Australia. School of Medicine, University of Melbourne, Melbourne, VIC, Australia.
- 700 1_
- $a Saad, Syed $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Sola, Laura $u Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay.
- 700 1_
- $a Tchokhonelidze, Irma $u Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia.
- 700 1_
- $a Tesar, Vladimir $u Department of Nephrology, General University Hospital, Charles University, Prague, Czech Republic.
- 700 1_
- $a Tungsanga, Kriang $u Department of Medicine, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, Thailand. Bhumirajanagarindra Kidney Institute, Bangkok, Thailand.
- 700 1_
- $a Turan Kazancioglu, Rumeyza $u Division of Nephrology, Bezmialem Vakif University, Istanbul, Turkey.
- 700 1_
- $a Wang, Angela Yee-Moon $u Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong.
- 700 1_
- $a Wiebe, Natasha $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Yang, Chih-Wei $u Kidney Research Center, Department of Nephrology, Chang Gung Memorial Hospital, Linkou, Taiwan. College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- 700 1_
- $a Zemchenkov, Alexander $u Department of Internal Disease and Nephrology, North-Western State Medical University named after I I Mechnikov, Saint Petersburg, Russia. Department of Nephrology and Dialysis, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia.
- 700 1_
- $a Zhao, Ming-Hui $u Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Key Lab of Renal Disease, Ministry of Health of China, Beijing, China. Key Lab of Chronic Kidney Disease Prevention and Treatment, Ministry of Education of China; Beijing, China. Peking-Tsinghua Center for Life Sciences, Beijing, China.
- 700 1_
- $a Jager, Kitty J $u ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Amsterdam Public Health Research Institute, University of Amsterdam, Amsterdam, Netherlands.
- 700 1_
- $a Caskey, Fergus $u Population Health Sciences, University of Bristol, Bristol, UK. Richard Bright Renal Unit, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.
- 700 1_
- $a Perkovic, Vlado $u George Institute for Global Health, University of New South Wales Sydney, Sydney, NSW, Australia.
- 700 1_
- $a Jindal, Kailash K $u Division of Nephrology and Immunology, Department of Medicine, University of Alberta, Edmonton, AB T6B 2B7, Canada.
- 700 1_
- $a Okpechi, Ikechi G $u Division of Nephrology and Hypertension, University of Cape Town, Cape Town, South Africa. Kidney and Hypertension Research Unit, University of Cape Town, Cape Town, South Africa.
- 700 1_
- $a Tonelli, Marcello $u Department of Medicine, University of Calgary, Calgary, AB, Canada. Pan-American Health Organization/World Health Organization's Collaborating Centre in Prevention and Control of Chronic Kidney Disease, University of Calgary, Calgary, AB, Canada.
- 700 1_
- $a Feehally, John $u University of Leicester, Leicester, UK.
- 700 1_
- $a Harris, David C $u Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
- 700 1_
- $a Johnson, David W $u Centre for Kidney Disease Research, University of Queensland, Brisbane, QLD, Australia. Translational Research Institute, Brisbane, QLD, Australia. Metro South and Ipswich Nephrology and Transplant Services, Princess Alexandra Hospital, Brisbane, QLD, Australia.
- 773 0_
- $w MED00193492 $t BMJ (Clinical research ed.) $x 1756-1833 $g Roč. 367, č. - (2019), s. l5873
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31672760 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200320112033 $b ABA008
- 999 __
- $a ok $b bmc $g 1482767 $s 1083171
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 367 $c - $d l5873 $e 20191031 $i 1756-1833 $m BMJ $n BMJ $x MED00193492
- LZP __
- $a Pubmed-20200109
